A number of 99Mo shortages in Australia in 2018 and 2019 drove lobbying for substitution of some PET procedures as equivalent for the same Medicare rebate/reimbursement approved for general nuclear medicine. Approval of 18F NaF bone PET as a substitute for bone scans in all pathologies had the largest impact with respect to patient numbers and relieving 99m Tc utilisation. This review provides a case-based insight into the initial experience of using 18F NaF PET bone scanning as a substitute for 99m Tc based bone scanning on a gamma camera; highlighting application in a variety of pathologies.
|Number of pages||4|
|Journal||Journal of Nuclear Medicine and Radiation Therapy|
|Publication status||Published - 2019|